Catalyst
Slingshot members are tracking this event:
Pluristem (PSTI) Completes Enrollment in Phase 2 Trial Evaluating PLX-PAD in Intermittent Claudication
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PSTI |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 12, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Enrollment, Phase 2, Plx-pad, Intermittent Claudication, Peripheral Artery Disease
